|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 24/04/14 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 23/04/14 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 01/10/2023 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 01/04/2017 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/01/2015 | |
Haruhisa Inada
BRD | Director/Board Member | - | 30/04/2014 |
Shingo Torii
BRD | Director/Board Member | 73 | 01/05/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.85% | +1.61% | -7.91% | -20.63% | 250B | ||
| -0.12% | -2.88% | -1.00% | -43.70% | 51.45B | ||
| -3.95% | +0.56% | -39.72% | -52.68% | 42.15B | ||
| -1.52% | +0.87% | -40.41% | -53.98% | 20.42B | ||
| +0.18% | -1.80% | -22.58% | -60.06% | 18.59B | ||
| -2.36% | 0.00% | -46.98% | -66.89% | 15.27B | ||
| -2.67% | -1.53% | -1.67% | -49.58% | 12.86B | ||
| +4.53% | -0.01% | -7.42% | +24.97% | 9.15B | ||
| -5.27% | -7.54% | +14.01% | -40.28% | 8.77B | ||
| Average | -1.46% | +0.06% | -17.08% | -40.32% | 47.58B | |
| Weighted average by Cap. | -1.72% | +0.69% | -13.14% | -31.81% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















